Nuveen Asset Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $990K | Sell |
92,957
-56,430
| -38% | -$601K | ﹤0.01% | 2716 |
|
|
2024
Q3 | $1.9M | Buy |
149,387
+56,430
| +61% | +$717K | ﹤0.01% | 2437 |
|
|
2024
Q2 | $1.56M | Buy |
92,957
+9,538
| +11% | +$160K | ﹤0.01% | 2504 |
|
|
2024
Q1 | $1.25M | Hold |
83,419
| – | – | ﹤0.01% | 2606 |
|
|
2023
Q4 | $1.25M | Buy |
83,419
+19,785
| +31% | +$297K | ﹤0.01% | 2624 |
|
|
2023
Q3 | $892K | Buy |
63,634
+2,172
| +4% | +$30.4K | ﹤0.01% | 2620 |
|
|
2023
Q2 | $636K | Buy |
+61,462
| New | +$636K | ﹤0.01% | 2842 |
|
|
2022
Q2 | – | Sell |
-94,660
| Closed | -$854K | – | 3401 |
|
|
2022
Q1 | $854K | Buy |
94,660
+908
| +1% | +$8.19K | ﹤0.01% | 2867 |
|
|
2021
Q4 | $906K | Sell |
93,752
-6,564
| -7% | -$63.4K | ﹤0.01% | 2890 |
|
|
2021
Q3 | $1.67M | Buy |
100,316
+3,716
| +4% | +$62K | ﹤0.01% | 2756 |
|
|
2021
Q2 | $1.48M | Sell |
96,600
-6,054
| -6% | -$92.4K | ﹤0.01% | 2843 |
|
|
2021
Q1 | $2M | Sell |
102,654
-95,036
| -48% | -$1.85M | ﹤0.01% | 2622 |
|
|
2020
Q4 | $3.56M | Sell |
197,690
-42,558
| -18% | -$767K | ﹤0.01% | 2240 |
|
|
2020
Q3 | $4.64M | Sell |
240,248
-96,901
| -29% | -$1.87M | ﹤0.01% | 1957 |
|
|
2020
Q2 | $8.81M | Buy |
337,149
+66,316
| +24% | +$1.73M | ﹤0.01% | 1565 |
|
|
2020
Q1 | $4.83M | Buy |
+270,833
| New | +$4.83M | ﹤0.01% | 1733 |
|
|
2019
Q4 | – | Sell |
-45,444
| Closed | -$1.08M | – | 3203 |
|
|
2019
Q3 | $1.08M | Buy |
45,444
+2,618
| +6% | +$62.4K | ﹤0.01% | 2666 |
|
|
2019
Q2 | $1.54M | Buy |
+42,826
| New | +$1.54M | ﹤0.01% | 2554 |
|